首页> 中国专利> 一种用于产后腹直肌分离评估练习的可穿戴教具

一种用于产后腹直肌分离评估练习的可穿戴教具

页面导航

摘要
著录项
相似文献

摘要

本实用新型公开了一种用于产后腹直肌分离评估练习的可穿戴教具，包括皮肤模拟层，所述皮肤模拟层两侧的上下两端均固定连接有系带，所述皮肤模拟层的上表面中部设置有模拟肚脐，且所述模拟肚脐的周围设置有模拟妊娠纹，所述皮肤模拟层的下侧设置有前腹壁腹直肌模拟层，所述前腹壁腹直肌模拟层的下侧设置有腹部内层肌肉模拟层，本实用新型通过模拟人体腹直肌的组成，能够在教学中便于学生进行实际了解，相对于传统的教学方式，能够起到很好的教学效果，并且通过设置有分离缝以及挂钩和钩扣，在进行教学时，能够通过调节挂钩与钩扣的卡合位置，从而对分离缝的大小进行调节，能够模拟不同程度的腹直肌分离状态，便于学生理解。

著录项

公开/公告号CN215730314U

专利类型实用新型
公开/公告日2022-02-01

原文格式PDF
申请/专利权人宁波卫生职业技术学院;
展开▼

申请/专利号CN202121926159.8
发明设计人王艳;苏晓敏;姚慧娇;
展开▼

申请日2021-08-17
分类号G09B9/00(20060101);G09B23/28(20060101);
代理机构33375 台州嘉卫专利代理事务所(普通合伙);
代理人蔡卫勇
地址 315192 浙江省宁波市鄞州区学府路51号
入库时间 2022-08-23 04:26:02

相似文献

专利
中文文献
外文文献

1. 一种用于产后腹直肌分离评估练习的可穿戴教具 [P] . 中国专利： CN215730314U . 2022-02-01
2. 一种产后腹直肌分离闭合恢复仪稳定装置 [P] . 中国专利： CN212757024U . 2021-03-23
3. Polinucleotu00eddeo insulated tape of expression, host cell, isolated transgenic non-human animal polypeptide, which has been modified to express a polypeptide mutant with resistance to ALK, antibody that binds specifically to a polypeptide mutant with resistance to ALK, kit p For detection of a mutation with resistance to ALK inhibitor in a biological sample, and,Methods for evaluating a biological sample as a mutation with resistance to ALK inhibitor, for diagnosing a cancer that is resistant to or is likely to develop resistance to at least one inhibitor of kinase small molecule ALK, to evaluate a biological sample that Anto a mutation with resistance to ALK inhibitor.For diagnosing a cancer that is resistant to or is likely to develop resistance to at least one inhibitor of kinase small molecule ALK, to assess the biological sample as a mutation with resistance to ALK inhibitor, a cancer that is resistant to dianosticar Or is likely to develop resistance to PF - 02341066 in a pati [P] . BR112012026239A2 . 2016-11-29

机译：修饰的多聚核苷酸绝缘带，宿主细胞，分离的转基因非人类动物多肽，经过修饰以表达对ALK具有抗性的多肽突变体，与对ALK具有抗性的多肽突变体特异性结合的抗体，试剂盒p用于检测生物样品中对ALK抑制剂具有抗性的突变，以及用于评估生物样品为对ALK抑制剂具有抗性的突变的方法，用于诊断对至少一种对ALK抑制剂具有抗性或可能发展出抗性的癌症激酶小分子ALK，以评估Anto对ALK抑制剂具有抗性的突变的生物样品。用于诊断对至少一种激酶小分子ALK抑制剂具有抗药性或可能产生抗性的癌症，以评估该生物样品作为对ALK抑制剂有抗性的突变，即对狄诺司他抗性或可能对PF产生抗药性的癌症-02341066
4. isolated polynucleotide, expression cassette, host cell, isolated polypeptide, non-human transgenic animal that has been altered to express an alkali resistant mutant polypeptide, an antibody that specifically binds to an alkali resistant mutant polypeptide, a mutation detection kit alk inhibitor resistance in a biological sample, and methods for evaluating a biological sample for an alk inhibitor resistance mutation to diagnose cancer that is resistant to or likely to develop resistance to at least one alkaline inhibitor. small alk molecule kinase, to evaluate a biological sample for an alk inhibitor resistance mutation, to diagnose cancer that is resistant to or likely to develop resistance to pf-02341066 in a patient, to specifically reduce expression of an alk-resistant mutant to treat cancer associated with activating aberrant loop capacity that is resistant to at least one small molecule alk kinase inhibitor treating an aberrant cancer that is resistant to pf-02341066, identifyin [P] . BR112012026239A2 . 2018-06-26

机译：分离的多核苷酸，表达盒，宿主细胞，分离的多肽，已被改变以表达耐碱突变体多肽的非人类转基因动物，与耐碱突变体多肽特异性结合的抗体，突变检测试剂盒生物样品，以及用于评估生物样品中是否存在对烷基抑制剂的抗性突变以诊断对至少一种碱性抑制剂有抗药性或可能发展出抗药性的癌症的方法。小分子激酶，用于评估生物学样品中是否具有抑制碱性磷酸酶抑制剂的突变，以诊断对患者具有抗药性或可能对pf-02341066产生抗药性的癌症，从而特异性降低抗癌突变体的表达以治疗癌症与激活抗至少一种小分子烷基激酶抑制剂的异常环路能力有关，该抑制剂治疗对pf-02341066有抵抗力的异常癌症
5. Nucleic acid, nucleic acid sequence, processes using a nucleic acid, using the vector, producing the polipeptu00ecdeo, administering the polipeptu00ecdeo,To treat a disease or disorder in an animal I, to determine if a disease or disorder in an animal I, to produce any polipeptu00ecdeo,Process for identifying, isolating and amplifying a nucleic acid sequence of neublastina,To diagnose or assess for the presence of a disease or disorder or a predisposiu00e7u00e3opara desnvolvu00ea them,To evaluate a polipeptu00ecdeo of neublastina purified or a derivative or fragment of a modulator activity of precedents for activity in treating or preventing a disease.To treat a neurological distu00fabio, using a sequence of one or more nucleic acids, and for identifying a candidate compound that induces a biological effect mediated by neuroblastina, vector,The cell transformed with nucleic acid, polipeptu00ecdeo, cmposiu00e7u00e3o, antibody, synthetic gene, and set. [P] . BR9911908A . 2001-03-27

机译：核酸，核酸序列，使用核酸的过程，使用载体的过程，产生聚肽，施用聚肽以治疗动物I中的疾病或失调，以确定动物中的疾病或失调I，生产任何脂肽，鉴定，分离和扩增神经母细胞核素核酸序列的方法，诊断或评估疾病或病症或它们的易感性，评估纯化的神经母细胞的脂肽或先例的调节剂活性的衍生物或片段，用于治疗或预防疾病。使用一种或多种核酸序列治疗神经系统疾病，并鉴定候选化合物诱导由神经母细胞，载体介导的生物学效应的细胞，该细胞用核酸，lipeptept，cmposi，抗体，合成基因和集合转化。